We are live on ! Find out more
CIP

Chartwell Investment Partners Portfolio holdings

AUM $2.91B
1-Year Est. Return 40.48%
This Fund
S&P 500
This Quarter Est. Return
+3.22%
1 Year Est. Return
+40.48%
3 Year Est. Return
+57.16%
5 Year Est. Return
+148.97%
10 Year Est. Return
+397.87%
AUM
$4.8B
AUM Growth
-$125M
Cap. Flow
-$257M
Cap. Flow %
-5.36%
Top 10 Hldgs %
12.1%
Holding
369
New
28
Increased
107
Reduced
151
Closed
31

Sector Composition

Rank Sector Weight
1 Industrials 15.99%
2 Consumer Discretionary 15.9%
3 Financials 13.97%
4 Technology 13.72%
5 Healthcare 11.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MGNX icon
226
MacroGenics
MGNX
$255M
$6.15M 0.13%
282,899
+37,689
+15% +$792K
FIVE icon
227
Five Below
FIVE
$12.8B
$6.14M 0.13%
153,831
-162,419
-51% -$6.2M
EPD icon
228
Enterprise Products Partners
EPD
$82.3B
$6.07M 0.13%
155,000
STT icon
229
State Street
STT
$50.8B
$6.06M 0.13%
90,050
+40,000
+80% +$2.63M
KMI icon
230
Kinder Morgan
KMI
$69.7B
$5.98M 0.12%
164,925
-5,220
-3% -$176K
PG icon
231
Procter & Gamble
PG
$342B
$5.96M 0.12%
75,793
-5,438
-7% -$438K
EXPR
232
DELISTED
Express, Inc.
EXPR
$5.93M 0.12%
+17,403
New +$5.2M
KSS icon
233
Kohl's
KSS
$2.09B
$5.93M 0.12%
112,495
+7,685
+7% +$416K
NSC icon
234
Norfolk Southern
NSC
$76.9B
$5.65M 0.12%
54,855
-2,605
-5% -$256K
VRA icon
235
Vera Bradley
VRA
$96.1M
$5.64M 0.12%
+257,746
New +$6.78M
SBNY
236
DELISTED
Signature Bank
SBNY
$5.55M 0.12%
44,016
-31,785
-42% -$3.82M
AEGR
237
DELISTED
Aegerion Pharmaceuticals
AEGR
$5.55M 0.12%
173,025
-34,845
-17% -$1.3M
NPSP
238
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$5.53M 0.12%
167,189
-98,046
-37% -$2.83M
COWN
239
DELISTED
Cowen Inc. Class A Common Stock
COWN
$5.52M 0.12%
+326,975
New +$5.39M
HON icon
240
Honeywell
HON
$76.3B
$5.47M 0.11%
65,550
ADP icon
241
Automatic Data Processing
ADP
$109B
$5.47M 0.11%
78,591
AJG icon
242
Arthur J. Gallagher & Co
AJG
$64.5B
$5.44M 0.11%
116,675
+60,915
+109% +$2.78M
EMC
243
DELISTED
EMC CORPORATION
EMC
$5.39M 0.11%
204,500
FELE icon
244
Franklin Electric
FELE
$4.83B
$5.18M 0.11%
128,361
-139,900
-52% -$5.55M
GILD icon
245
Gilead Sciences
GILD
$162B
$5.12M 0.11%
+61,800
New +$4.81M
MRO
246
DELISTED
Marathon Oil Corporation
MRO
$4.95M 0.1%
124,000
-100
-0.1% -$3.69K
NOV icon
247
NOV
NOV
$7.09B
$4.94M 0.1%
60,000
-6,540
-10% -$487K
CAH icon
248
Cardinal Health
CAH
$55.7B
$4.8M 0.1%
70,000
MET icon
249
MetLife
MET
$64.3B
$4.75M 0.1%
95,987
-10,098
-10% -$473K
ROK icon
250
Rockwell Automation
ROK
$49.2B
$4.68M 0.1%
37,415
+28,000
+297% +$3.45M

Similar funds

Chartwell Investment Partners's Q2 2014 Portfolio in Review

As of Q2 2014, Chartwell Investment Partners held 369 positions worth $4.8B, down 2.5% from $4.92B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Chartwell Investment Partners withdrew a net $257M in Q2 2014, closing 31 positions and reducing 151 holdings. Its most notable exit was Finisar Corp, an estimated $68.9M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Chartwell Investment Partners opened a new position in Allergan plc worth $51.6M.

  • Chartwell Investment Partners's largest Q2 2014 buy was Allergan plc: 231,460 shares worth $51.6M.
  • Chartwell Investment Partners added most to Brunswick in Q2 2014, an estimated $23.5M increase.
  • Chartwell Investment Partners's biggest Q2 2014 reduction was Hanesbrands, cutting an estimated $40.1M.
  • Chartwell Investment Partners fully exited Finisar Corp in Q2 2014, selling an estimated $68.9M.
  • Chartwell Investment Partners's ten largest holdings make up 12% of its $4.8B portfolio in Q2 2014.
  • Chartwell Investment Partners opened 28 new positions and closed 31 in Q2 2014.
  • Chartwell Investment Partners's portfolio value fell 2.5% quarter-over-quarter to $4.8B.

Based on Chartwell Investment Partners's 13F filing for Q2 2014, filed 13 Aug 2014.